PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Sep 10, 2026 8-K
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
SCHEDULE 13G Jul 8, 2026
4 Jun 10, 2026 4
4 Jun 10, 2026 PRIMARY DOCUMENT
4 Jun 10, 2026 PRIMARY DOCUMENT
4 Jun 10, 2026 PRIMARY DOCUMENT
4 Jun 10, 2026 PRIMARY DOCUMENT
4 Jun 10, 2026 PRIMARY DOCUMENT
8-K Jun 10, 2026 8-K
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
4 May 4, 2026 PRIMARY DOCUMENT
ARS Apr 29, 2026 ARS
DEFA14A Apr 29, 2026 DEFA14A
DEF 14A Apr 29, 2026 DEF 14A
SCHEDULE 13G Apr 28, 2026
4 Apr 28, 2026
3 Apr 28, 2026
SCHEDULE 13D/A Apr 23, 2026
4 Apr 23, 2026
4 Apr 23, 2026
SCHEDULE 13D/A Apr 22, 2026
4 Apr 22, 2026 4
← Newer Page 1 of 16 · 389 filings Older →